Opioid use disorder (OUD) can involve misuse of prescribed opioid medications, use of diverted opioid medications, or use of illicitly obtained heroin. OUD is typically a chronic, relapsing illness, associated with significantly increased rates of morbidity and mortality.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Opioid Use Disorder industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Buprenorphine
Methadone
Naltrexone
Market Segment by Product Application
Moderate Pain Treatment
Severe Pain Treatment
Finally, the report provides detailed profile and data information analysis of leading company.
Indivior
Alkermes
Titan Pharmaceuticals
Hikma Pharmaceuticals
Teva Pharmaceuticals
MediciNova
Orexo
Camurus
Omeros
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Opioid Use Disorder consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Opioid Use Disorder market by identifying its various subsegments.
3.Focuses on the key global Opioid Use Disorder manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Opioid Use Disorder with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Opioid Use Disorder submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Opioid Use Disorder Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Opioid Use Disorder Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Opioid Use Disorder Segment by Type
2.1.1 Buprenorphine
2.1.2 Methadone
2.1.3 Naltrexone
2.2 Market Analysis by Application
2.2.1 Moderate Pain Treatment
2.2.2 Severe Pain Treatment
2.3 Global Opioid Use Disorder Market Comparison by Regions (2017-2027)
2.3.1 Global Opioid Use Disorder Market Size (2017-2027)
2.3.2 North America Opioid Use Disorder Status and Prospect (2017-2027)
2.3.3 Europe Opioid Use Disorder Status and Prospect (2017-2027)
2.3.4 China Opioid Use Disorder Status and Prospect (2017-2027)
2.3.5 Japan Opioid Use Disorder Status and Prospect (2017-2027)
2.3.6 Southeast Asia Opioid Use Disorder Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Opioid Use Disorder Industry Impact
2.5.1 Opioid Use Disorder Business Impact Assessment - Covid-19
2.5.2 Market Trends and Opioid Use Disorder Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Opioid Use Disorder Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Opioid Use Disorder Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Opioid Use Disorder Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Opioid Use Disorder Manufacturer Market Share
3.5 Top 10 Opioid Use Disorder Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Opioid Use Disorder Market
3.7 Key Manufacturers Opioid Use Disorder Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Opioid Use Disorder Industry Key Manufacturers
4.1 Indivior
4.1.1 Compan Detail
4.1.2 Indivior Opioid Use Disorder Product Introduction, Application and Specification
4.1.3 Indivior 130 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Indivior News
4.2 Alkermes
4.2.1 Compan Detail
4.2.2 Alkermes Opioid Use Disorder Product Introduction, Application and Specification
4.2.3 Alkermes Opioid Use Disorder Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Indivior News
4.3 Titan Pharmaceuticals
4.3.1 Compan Detail
4.3.2 Titan Pharmaceuticals Opioid Use Disorder Product Introduction, Application and Specification
4.3.3 Titan Pharmaceuticals Opioid Use Disorder Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Titan Pharmaceuticals News
4.4 Hikma Pharmaceuticals
4.4.1 Compan Detail
4.4.2 Hikma Pharmaceuticals Opioid Use Disorder Product Introduction, Application and Specification
4.4.3 Hikma Pharmaceuticals Opioid Use Disorder Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Hikma Pharmaceuticals News
4.5 Teva Pharmaceuticals
4.5.1 Compan Detail
4.5.2 Hikma Pharmaceuticals Opioid Use Disorder Product Introduction, Application and Specification
4.5.3 Teva Pharmaceuticals Opioid Use Disorder Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Teva Pharmaceuticals News
4.6 MediciNova
4.6.1 Compan Detail
4.6.2 MediciNova Opioid Use Disorder Product Introduction, Application and Specification
4.6.3 MediciNova Opioid Use Disorder Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 MediciNova News
4.7 Orexo
4.7.1 Compan Detail
4.7.2 Orexo Opioid Use Disorder Product Introduction, Application and Specification
4.7.3 Orexo Opioid Use Disorder Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Camurus
4.8.1 Compan Detail
4.8.2 Camurus Opioid Use Disorder Product Introduction, Application and Specification
4.8.3 Camurus Opioid Use Disorder Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Camurus News
4.9 Omeros
4.9.1 Compan Detail
4.9.2 Omeros Opioid Use Disorder Product Introduction, Application and Specification
4.9.3 Omeros Opioid Use Disorder Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Omeros News
5 Global Opioid Use Disorder Market Segment by Big Type
5.1 Global Opioid Use Disorder Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Opioid Use Disorder Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Opioid Use Disorder Revenue and Market Share by Big Type (2017-2022)
5.2 Buprenorphine Sales Growth Rate and Price
5.2.1 Global Buprenorphine Sales Growth Rate (2017-2022)
5.2.2 Global Buprenorphine Price (2017-2022)
5.3 Methadone Sales Growth Rate and Price
5.3.1 Global Methadone Sales Growth Rate (2017-2022)
5.3.2 Global Methadone Price (2017-2022)
5.4 Naltrexone Sales Growth Rate and Price
5.4.1 Global Naltrexone Sales Growth Rate (2017-2022)
5.4.2 Global Naltrexone Price (2017-2022)
6 Global Opioid Use Disorder Market Segment by Big Application
6.1 Global Opioid Use Disorder Sales Market Share by Big Application (2017-2022)
6.2 Moderate Pain Treatment Sales Growth Rate (2017-2022)
6.3 Severe Pain Treatment Sales Growth Rate (2017-2022)
7 Global Opioid Use Disorder Forecast
7.1 Global Opioid Use Disorder Revenue, Sales and Growth Rate (2022-2027)
7.2 Opioid Use Disorder Market Forecast by Regions (2022-2027)
7.2.1 North America Opioid Use Disorder Market Forecast (2022-2027)
7.2.2 Europe Opioid Use Disorder Market Forecast (2022-2027)
7.2.3 China Opioid Use Disorder Market Forecast (2022-2027)
7.2.4 Japan Opioid Use Disorder Market Forecast (2022-2027)
7.2.5 Southeast Asia Opioid Use Disorder Market Forecast (2022-2027)
7.2.6 Other Regions Opioid Use Disorder Market Forecast (2022-2027)
7.3 Opioid Use Disorder Market Forecast by Type (2022-2027)
7.3.1 Global Opioid Use Disorder Sales Forecast by Type (2022-2027)
7.3.2 Global Opioid Use Disorder Market Share Forecast by Type (2022-2027)
7.4 Opioid Use Disorder Market Forecast by Application (2022-2027)
7.4.1 Global Opioid Use Disorder Sales Forecast by Application (2022-2027)
7.4.2 Global Opioid Use Disorder Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Opioid Use Disorder Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Opioid Use Disorder Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Opioid Use Disorder
Figure Market Concentration Ratio and Market Maturity Analysis of Opioid Use Disorder
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Opioid Use Disorder Market Size by Big Type
Figure Global Market Share of Opioid Use Disorder by Big Type in 2021
Figure Buprenorphine Picture (2017-2022)
Figure Methadone Picture (2017-2022)
Global Opioid Use Disorder Market Size by Big Application
Table Global Opioid Use Disorder Market Size by Application
Figure Global Opioid Use Disorder Market Share by Big Application in 2021
Figure Moderate Pain Treatment Picture
Figure Severe Pain Treatment Picture
Table Global Opioid Use Disorder Comparison by Regions (M USD) (2017-2027)
Figure Global Opioid Use Disorder Market Size (Million US$) (2017-2027)
Figure North America Opioid Use Disorder Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Opioid Use Disorder Revenue (Million US$) Growth Rate (2017-2027)
Figure China Opioid Use Disorder Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Opioid Use Disorder Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Opioid Use Disorder Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Opioid Use Disorder Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Opioid Use Disorder Sales by Manufacturer (2017-2022)
Figure Global Opioid Use Disorder Sales Market Share by Manufacturer in 2021
Table Global Opioid Use Disorder Revenue by Manufacturer (2017-2022)
Figure Global Opioid Use Disorder Revenue Market Share by Manufacturer in 2021
Table Global Opioid Use Disorder Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Opioid Use Disorder Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Opioid Use Disorder Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Opioid Use Disorder Market
Table Key Manufacturers Opioid Use Disorder Product Type
Table Mergers & Acquisitions Planning
Table Indivior Company Profile
Table Opioid Use Disorder Product Introduction, Application and Specification of Indivior
Table Opioid Use Disorder Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Alkermes Company Profile
Table Opioid Use Disorder Product Introduction, Application and Specification of Alkermes
Table Opioid Use Disorder Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Alkermes Recent Development
Table Titan Pharmaceuticals Company Profile
Table Opioid Use Disorder Product Introduction, Application and Specification of Titan Pharmaceuticals
Table Opioid Use Disorder Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Titan Pharmaceuticals Main Business
Table Titan Pharmaceuticals Recent Development
Table Hikma Pharmaceuticals Company Profile
Table Opioid Use Disorder Product Introduction, Application and Specification of Hikma Pharmaceuticals
Table Opioid Use Disorder Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Hikma Pharmaceuticals Main Business
Table Hikma Pharmaceuticals Recent Development
Table Hikma Pharmaceuticals Main Business
Table Hikma Pharmaceuticals Recent Development
Table Teva Pharmaceuticals Company Profile
Table Opioid Use Disorder Product Introduction, Application and Specification of Teva Pharmaceuticals
Table Opioid Use Disorder Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Teva Pharmaceuticals Main Business
Table Teva Pharmaceuticals Recent Development
Table MediciNova Company Profile
Table Opioid Use Disorder Product Introduction, Application and Specification of MediciNova
Table Opioid Use Disorder Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table MediciNova Main Business
Table MediciNova Recent Development
Table Orexo Company Profile
Table Opioid Use Disorder Product Introduction, Application and Specification of Orexo
Table Opioid Use Disorder Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Orexo Main Business
Table Orexo Recent Development
Table Camurus Company Profile
Table Opioid Use Disorder Product Introduction, Application and Specification of Camurus
Table Opioid Use Disorder Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Camurus Main Business
Table Camurus Recent Development
Table Omeros Company Profile
Table Opioid Use Disorder Product Introduction, Application and Specification of Omeros
Table Opioid Use Disorder Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Omeros Main Business
Table Omeros Recent Development
Figure Global Opioid Use Disorder Sales and Growth Rate (2017-2022)
Figure Global Opioid Use Disorder Revenue and Growth Rate (2017-2022)
Table Global Opioid Use Disorder Sales by Regions (2017-2022)
Figure Global Opioid Use Disorder Sales Market Share by Regions in 2021
Table Global Opioid Use Disorder Revenue by Regions (2017-2022)
Figure Global Opioid Use Disorder Revenue Market Share by Regions in 2021
Figure North America Opioid Use Disorder Sales and Growth Rate (2017-2022)
Figure Europe Opioid Use Disorder Sales and Growth Rate (2017-2022)
Figure China Opioid Use Disorder Sales and Growth Rate (2017-2022)
Figure Japan Opioid Use Disorder Sales and Growth Rate (2017-2022)
Figure Southeast Asia Opioid Use Disorder Sales and Growth Rate (2017-2022)
Figure Other Regions Opioid Use Disorder Sales and Growth Rate (2017-2022)
Table Global Opioid Use Disorder Sales by Big Type (2017-2022)
Table Global Opioid Use Disorder Sales Market Share by Big Type (2017-2022)
Figure Global Opioid Use Disorder Sales Market Share by Big Type in 2019
Table Global Opioid Use Disorder Revenue by Big Type (2017-2022)
Table Global Opioid Use Disorder Revenue Market Share by Big Type (2017-2022)
Table Global Opioid Use Disorder Revenue Market Share by Big Type in 2019
Figure Global Buprenorphine Sales Growth Rate (2017-2022)
Figure Global Buprenorphine Price (2017-2022)
Figure Global Methadone Sales Growth Rate (2017-2022)
Figure Global Methadone Price (2017-2022)
Figure Global Naltrexone Sales Growth Rate (2017-2022)
Table Global Opioid Use Disorder Sales by Big Application (2017-2022)
Table Global Opioid Use Disorder Sales Market Share by Big Application (2017-2022)
Figure Global Opioid Use Disorder Sales Market Share by Big Application in 2019
Figure Global Moderate Pain Treatment Sales Growth Rate (2017-2022)
Figure Global Severe Pain Treatment Sales Growth Rate (2017-2022)
Figure Global Opioid Use Disorder Sales and Growth Rate (2022-2027)
Figure Global Opioid Use Disorder Revenue and Growth Rate (2022-2027)
Table Global Opioid Use Disorder Sales Forecast by Regions (2022-2027)
Table Global Opioid Use Disorder Market Share Forecast by Regions (2022-2027)
Figure North America Sales Opioid Use Disorder Market Forecast (2022-2027)
Figure Europe Sales Opioid Use Disorder Market Forecast (2022-2027)
Figure China Sales Opioid Use Disorder Market Forecast (2022-2027)
Figure Japan Sales Opioid Use Disorder Market Forecast (2022-2027)
Figure Southeast Asia Sales Opioid Use Disorder Market Forecast (2022-2027)
Figure Other Regions Sales Opioid Use Disorder Market Forecast (2022-2027)
Table Global Opioid Use Disorder Sales Forecast by Type (2022-2027)
Table Global Opioid Use Disorder Market Share Forecast by Type (2022-2027)
Table Global Opioid Use Disorder Sales Forecast by Application (2022-2027)
Table Global Opioid Use Disorder Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Opioid Use Disorder
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Opioid Use Disorder Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Opioid Use Disorder Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Opioid Use Disorder Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Opioid Use Disorder Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Opioid Use Disorder Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Opioid Use Disorder Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Opioid Use Disorder Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Opioid Use Disorder Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Indivior
Alkermes
Titan Pharmaceuticals
Hikma Pharmaceuticals
Teva Pharmaceuticals
MediciNova
Orexo
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)